Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 11 | 2024 | 2647 | 2.100 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 2024 | 39 | 1.730 |
Why?
|
| Lung | 8 | 2024 | 1253 | 1.220 |
Why?
|
| Pulmonary Fibrosis | 2 | 2024 | 133 | 1.050 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2023 | 253 | 0.980 |
Why?
|
| Radiology Information Systems | 2 | 2023 | 78 | 0.930 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 411 | 0.900 |
Why?
|
| Lung Neoplasms | 4 | 2024 | 2344 | 0.870 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2022 | 48 | 0.830 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 112 | 0.770 |
Why?
|
| Myocarditis | 1 | 2021 | 51 | 0.770 |
Why?
|
| Pneumonia | 1 | 2022 | 182 | 0.750 |
Why?
|
| Spinal Diseases | 1 | 2019 | 44 | 0.670 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1175 | 0.630 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 151 | 0.620 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 666 | 0.560 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 3441 | 0.510 |
Why?
|
| Transplant Recipients | 1 | 2016 | 137 | 0.490 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 345 | 0.440 |
Why?
|
| HIV Infections | 1 | 2020 | 830 | 0.390 |
Why?
|
| Lung Diseases | 2 | 2023 | 269 | 0.380 |
Why?
|
| Humans | 25 | 2024 | 88835 | 0.370 |
Why?
|
| Aged | 9 | 2024 | 19014 | 0.330 |
Why?
|
| Retrospective Studies | 9 | 2024 | 8960 | 0.330 |
Why?
|
| Middle Aged | 11 | 2024 | 25783 | 0.310 |
Why?
|
| Computed Tomography Angiography | 2 | 2019 | 141 | 0.300 |
Why?
|
| Male | 13 | 2024 | 42127 | 0.290 |
Why?
|
| Female | 14 | 2024 | 45893 | 0.270 |
Why?
|
| Occupational Exposure | 2 | 2023 | 83 | 0.250 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2024 | 16 | 0.240 |
Why?
|
| Sensitivity and Specificity | 3 | 2024 | 2012 | 0.230 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 10 | 0.230 |
Why?
|
| Pneumoconiosis | 1 | 2023 | 5 | 0.230 |
Why?
|
| Pleural Effusion | 1 | 2023 | 47 | 0.220 |
Why?
|
| Occupational Diseases | 1 | 2023 | 55 | 0.220 |
Why?
|
| Nomograms | 1 | 2022 | 29 | 0.210 |
Why?
|
| Smoking | 2 | 2024 | 620 | 0.210 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 139 | 0.210 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 144 | 0.200 |
Why?
|
| Calcinosis | 1 | 2023 | 230 | 0.200 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 55 | 0.200 |
Why?
|
| Gadolinium | 1 | 2021 | 103 | 0.190 |
Why?
|
| Radiology | 1 | 2024 | 199 | 0.190 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 188 | 0.190 |
Why?
|
| Smoking Cessation | 1 | 2024 | 251 | 0.190 |
Why?
|
| Inositol | 1 | 2020 | 15 | 0.190 |
Why?
|
| Choline | 1 | 2020 | 24 | 0.190 |
Why?
|
| Medical History Taking | 1 | 2021 | 81 | 0.190 |
Why?
|
| Aspartic Acid | 1 | 2020 | 64 | 0.180 |
Why?
|
| Creatine | 1 | 2020 | 25 | 0.180 |
Why?
|
| Societies, Medical | 1 | 2024 | 566 | 0.180 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.180 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 51 | 0.180 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 130 | 0.180 |
Why?
|
| United States | 2 | 2024 | 6928 | 0.180 |
Why?
|
| Young Adult | 3 | 2021 | 6271 | 0.170 |
Why?
|
| Vaccination | 1 | 2021 | 273 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 312 | 0.170 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2019 | 41 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 143 | 0.160 |
Why?
|
| Consensus | 1 | 2021 | 355 | 0.160 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 168 | 0.160 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 478 | 0.160 |
Why?
|
| Environmental Exposure | 1 | 2021 | 321 | 0.160 |
Why?
|
| Coronary Angiography | 1 | 2019 | 239 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 197 | 0.150 |
Why?
|
| Vasopressins | 1 | 2018 | 50 | 0.150 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 98 | 0.150 |
Why?
|
| Adult | 7 | 2024 | 26437 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 56 | 0.150 |
Why?
|
| Brain Edema | 1 | 2018 | 58 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1039 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| Pelvis | 1 | 2017 | 96 | 0.140 |
Why?
|
| Patient Positioning | 1 | 2017 | 65 | 0.140 |
Why?
|
| Contrast Media | 1 | 2021 | 1090 | 0.140 |
Why?
|
| Extremities | 1 | 2017 | 168 | 0.140 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 181 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 227 | 0.130 |
Why?
|
| Sarcoma | 1 | 2017 | 220 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2021 | 2011 | 0.130 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 98 | 0.130 |
Why?
|
| Risk Factors | 4 | 2021 | 5447 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1712 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 770 | 0.120 |
Why?
|
| Global Health | 1 | 2015 | 186 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2018 | 399 | 0.120 |
Why?
|
| Adolescent | 3 | 2021 | 9201 | 0.110 |
Why?
|
| Incidence | 1 | 2015 | 1591 | 0.090 |
Why?
|
| Heart Failure | 1 | 2020 | 1172 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1040 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 2269 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 978 | 0.080 |
Why?
|
| Pregnancy | 1 | 2016 | 3002 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6757 | 0.060 |
Why?
|
| Eligibility Determination | 1 | 2024 | 36 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2024 | 341 | 0.050 |
Why?
|
| Mass Screening | 1 | 2024 | 631 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 249 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2018 | 43 | 0.040 |
Why?
|
| Catecholamines | 1 | 2018 | 91 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2853 | 0.040 |
Why?
|
| Rotation | 1 | 2017 | 91 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 1209 | 0.040 |
Why?
|
| Survival Rate | 1 | 2020 | 1880 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 372 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 502 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 609 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 468 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1849 | 0.030 |
Why?
|
| Child | 1 | 2017 | 7112 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8177 | 0.020 |
Why?
|